نتایج جستجو برای: gemistocytic glioblastomas

تعداد نتایج: 2385  

Journal: :New England Journal of Medicine 2011

2013
Kyu Sang Lee Gheeyoung Choe Kyung Han Nam An Na Seo Sumi Yun Kyung Ju Kim Hwa Jin Cho Sung Hye Park

BACKGROUND Glioblastomas may develop de novo (primary glioblastomas, P-GBLs) or through progression from lower-grade astrocytomas (secondary glioblastomas, S-GBLs). The aim of this study was to compare the immunohistochemical classification of glioblastomas with clinically determined P-GBLs and S-GBLs to identify the best combination of antibodies for immunohistochemical classification. METHO...

Journal: :Journal of neuroradiology. Journal de neuroradiologie 2016
Akio Hiwatashi Osamu Togao Koji Yamashita Kazufumi Kikuchi Koji Yoshimoto Masahiro Mizoguchi Satoshi O Suzuki Takashi Yoshiura Hiroshi Honda

OBJECTIVE Correction of contrast leakage is recommended when enhancing lesions during perfusion analysis. The purpose of this study was to assess the diagnostic performance of computed tomography perfusion (CTP) with a delay-invariant singular-value decomposition algorithm (SVD+) and a Patlak plot in differentiating glioblastomas from lymphomas. MATERIALS AND METHODS This prospective study in...

2013
Yoko Matsuda Hisashi Yoshimura Taeko Suzuki Toshiyuki Ishiwata

Glioblastomas are the most common primary malignant neoplasms in the adult brain, and have the characteristics of glial cells [1]. The WHO histopathological classification guidelines categorize gliomas according to their histopathological grades; low-grade gliomas are not anaplastic and are associated with a favorable patient prognosis, while high-grade gliomas exhibit increased cellularity, nu...

2014
Cheng Hong Toh Kuo-Chen Wei Chen-Nen Chang Shu-Hang Ng Ho-Fai Wong Ching-Po Lin Jon Sherman

PURPOSE To compare the diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MRI before and after mathematic contrast leakage correction in differentiating pyogenic brain abscesses from glioblastomas and/or metastatic brain tumors. MATERIALS AND METHODS Cerebral blood volume (CBV), leakage-corrected CBV and leakage coefficient K2 were measured in enhancing rims, perifoc...

2017
Tomohiro Sawa Takaaki Akaike

Glioblastomas are the most frequent and most malignant nervous system tumors [Stewart & Kleihues, 2003]. Despite technological advances in surgical treatment and new regimens of radiotherapy combined with chemotherapy, the median survival of patients with these tumors is approximately 1 year, and only 3% of patients survive more than 3 years [Stupp et al., 2005]. Glioblastomas have been traditi...

2001
Sun Joo Lee Jae Hyoung Kim Young Mee Kim Gyung Kyu Lee Eun Ja Lee In Sung Park Jin-Myung Jung Kyeong Hun Kang Taemin Shin

OBJECTIVE To determine the usefulness of perfusion MR imaging in assessing the histologic grade of cerebral gliomas. MATERIALS AND METHODS In order to determine relative cerebral blood volume (rCBV), 22 patients with pathologically proven gliomas (9 glioblastomas, 9 anaplastic gliomas and 4 low-grade gliomas) underwent dynamic contrast-enhanced T2*-weighted and conventional T1- and T2-weighte...

Journal: :AJNR. American journal of neuroradiology 2017
C H Toh M Castillo

BACKGROUND AND PURPOSE The serial imaging changes describing the growth of glioblastomas from small to large tumors are seldom reported. Our aim was to classify the imaging patterns of early-stage glioblastomas and to define the order of appearance of different imaging patterns that occur during the growth of small glioblastomas. MATERIALS AND METHODS Medical records and preoperative MR imagi...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Daniel P Cahill Kymberly K Levine Rebecca A Betensky Patrick J Codd Candice A Romany Linsey B Reavie Tracy T Batchelor P Andrew Futreal Michael R Stratton William T Curry A John Iafrate David N Louis

PURPOSE Glioblastomas are treated by surgical resection followed by radiotherapy [X-ray therapy (XRT)] and the alkylating chemotherapeutic agent temozolomide. Recently, inactivating mutations in the mismatch repair gene MSH6 were identified in two glioblastomas recurrent post-temozolomide. Because mismatch repair pathway inactivation is a known mediator of alkylator resistance in vitro, these f...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید